{"id": "NqDgVtcAAAAJ", "citedby": 19539, "citedby5y": 6527, "hindex": 71, "hindex5y": 39, "i10index": 142, "i10index5y": 90, "coauthors": [], "name": "Arthur Burghes", "affiliation": "Professor Molecular and Cellular Biochemistry", "interests": ["Neuromuscular Genetics"], "cites_per_year": {"1988": 114, "1989": 186, "1990": 158, "1991": 203, "1992": 175, "1993": 171, "1994": 190, "1995": 220, "1996": 231, "1997": 253, "1998": 268, "1999": 295, "2000": 354, "2001": 429, "2002": 404, "2003": 343, "2004": 364, "2005": 388, "2006": 504, "2007": 552, "2008": 685, "2009": 681, "2010": 981, "2011": 934, "2012": 1237, "2013": 1131, "2014": 1202, "2015": 1223, "2016": 1187, "2017": 1248, "2018": 1217, "2019": 1102, "2020": 528}, "publications": [{"bib": {"title": "A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:9yKSN-GCB0IC", "citedby": "826"}, {"bib": {"title": "The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:u5HHmVD_uO8C", "citedby": "743"}, {"bib": {"title": "The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2013/\u2013mice and results in a mouse with spinal muscular atrophy", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:d1gkVwhDpl0C", "citedby": "723"}, {"bib": {"title": "The survival motor neuron protein in spinal muscular atrophy", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:u-x6o8ySG0sC", "citedby": "689"}, {"bib": {"title": "Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?", "year": "2009"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:eQOLeE2rZwMC", "citedby": "631"}, {"bib": {"title": "Astrocytes from familial and sporadic ALS patients are toxic to motor neurons", "year": "2011"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:3fE2CSJIrl8C", "citedby": "616"}, {"bib": {"title": "Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:WF5omc3nYNoC", "citedby": "613"}, {"bib": {"title": "Single-dose gene-replacement therapy for spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LhH-TYMQEocC", "citedby": "595"}, {"bib": {"title": "Myoblast transfer in the treatment of Duchenne's muscular dystrophy", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:qjMakFHDy7sC", "citedby": "555"}, {"bib": {"title": "SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full \u2026", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Tyk-4Ss8FVUC", "citedby": "541"}, {"bib": {"title": "Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:2osOgNQ5qMEC", "citedby": "540"}, {"bib": {"title": "SMN oligomerization defect correlates with spinal muscular atrophy severity", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:UeHWp8X0CEIC", "citedby": "506"}, {"bib": {"title": "Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding", "year": "2003"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:zYLM7Y9cAGgC", "citedby": "431"}, {"bib": {"title": "Valproic acid increases SMN levels in spinal muscular atrophy patient cells", "year": "2003"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:W7OEmFMy1HYC", "citedby": "336"}, {"bib": {"title": "Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:IjCSPb-OGe4C", "citedby": "320"}, {"bib": {"title": "Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:roLk4NBRz8UC", "citedby": "318"}, {"bib": {"title": "A cDNA clone from the Duchenne/Becker muscular dystrophy gene", "year": "1987"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Y0pCki6q_DkC", "citedby": "308"}, {"bib": {"title": "When is a deletion not a deletion? When it is converted.", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:YsMSGLbcyi4C", "citedby": "286"}, {"bib": {"title": "Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2", "year": "2002"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:0EnyYjriUFMC", "citedby": "280"}, {"bib": {"title": "Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Se3iqnhoufwC", "citedby": "279"}, {"bib": {"title": "Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders", "year": "2011"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:TFP_iSt0sucC", "citedby": "275"}, {"bib": {"title": "Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ufrVoPGSRksC", "citedby": "255"}, {"bib": {"title": "A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:hC7cP41nSMkC", "citedby": "243"}, {"bib": {"title": "Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:UebtZRa9Y70C", "citedby": "231"}, {"bib": {"title": "Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene", "year": "1989"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:zLWjf1WUPmwC", "citedby": "221"}, {"bib": {"title": "Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:8AbLer7MMksC", "citedby": "218"}, {"bib": {"title": "Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:YOwf2qJgpHMC", "citedby": "207"}, {"bib": {"title": "Early heart failure in the SMN\u03947 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:L8Ckcad2t8MC", "citedby": "195"}, {"bib": {"title": "A positive modifier of spinal muscular atrophy in the SMN2 gene", "year": "2009"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_Qo2XoVZTnwC", "citedby": "191"}, {"bib": {"title": "Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:hqOjcs7Dif8C", "citedby": "183"}, {"bib": {"title": "Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis", "year": "2006"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:8k81kl-MbHgC", "citedby": "179"}, {"bib": {"title": "The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LkGwnXOMwfcC", "citedby": "167"}, {"bib": {"title": "Embryonic motor axon development in the severe SMA mouse", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Wp0gIr-vW9MC", "citedby": "164"}, {"bib": {"title": "High resolution two\u2010dimensional polyacrylamide gel electrophoresis. I. Methodological procedures", "year": "1983"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Zph67rFs4hoC", "citedby": "162"}, {"bib": {"title": "Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose\u2013response study in mice and nonhuman primates", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:oNZyr7d5Mn4C", "citedby": "152"}, {"bib": {"title": "Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:MXK_kJrjxJIC", "citedby": "152"}, {"bib": {"title": "Animal models of spinal muscular atrophy", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:KlAtU1dfN6UC", "citedby": "147"}, {"bib": {"title": "Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:mVmsd5A6BfQC", "citedby": "146"}, {"bib": {"title": "Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_kc_bZDykSQC", "citedby": "146"}, {"bib": {"title": "Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.", "year": "1992"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:kNdYIx-mwKoC", "citedby": "146"}, {"bib": {"title": "A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy", "year": "2003"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:M3ejUd6NZC8C", "citedby": "142"}, {"bib": {"title": "An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene", "year": "1996"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:5nxA0vEk-isC", "citedby": "140"}, {"bib": {"title": "Identification of survival motor neuron as a transcriptional activator-binding protein", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ULOm3_A8WrAC", "citedby": "135"}, {"bib": {"title": "Spectrum of small mutations in the dystrophin coding region.", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:aqlVkmm33-oC", "citedby": "134"}, {"bib": {"title": "Effects of 2, 4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:mB3voiENLucC", "citedby": "129"}, {"bib": {"title": "A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:QIV2ME_5wuYC", "citedby": "124"}, {"bib": {"title": "Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:7PzlFSSx8tAC", "citedby": "121"}, {"bib": {"title": "Temporal requirement for high SMN expression in SMA mice", "year": "2011"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:hMod-77fHWUC", "citedby": "116"}, {"bib": {"title": "Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:qxL8FJ1GzNcC", "citedby": "115"}, {"bib": {"title": "The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ZeXyd9-uunAC", "citedby": "112"}, {"bib": {"title": "Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity?", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4MWp96NkSFoC", "citedby": "112"}, {"bib": {"title": "Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: association of marker genotype with disease severity and candidate cDNAs", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4TOpqqG69KYC", "citedby": "107"}, {"bib": {"title": "A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ns9cj8rnVeAC", "citedby": "106"}, {"bib": {"title": "Protein\u2010and mRNA\u2010based phenotype\u2013genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:e5wmG9Sq2KIC", "citedby": "106"}, {"bib": {"title": "Abnormal motor phenotype in the SMN\u03947 mouse model of spinal muscular atrophy", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4JMBOYKVnBMC", "citedby": "103"}, {"bib": {"title": "A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:9ZlFYXVOiuMC", "citedby": "98"}, {"bib": {"title": "Synthesis and Biological Evaluation of Novel 2,4-Diaminoquinazoline Derivatives as SMN2 Promoter Activators for the Potential Treatment of Spinal Muscular \u2026", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:isC4tDSrTZIC", "citedby": "97"}, {"bib": {"title": "Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT)", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:RHpTSmoSYBkC", "citedby": "96"}, {"bib": {"title": "A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice", "year": "2009"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:maZDTaKrznsC", "citedby": "95"}, {"bib": {"title": "Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:R3hNpaxXUhUC", "citedby": "94"}, {"bib": {"title": "Partial gene duplication in Duchenne and Becker muscular dystrophies.", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:-f6ydRqryjwC", "citedby": "93"}, {"bib": {"title": "A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:g5m5HwL7SMYC", "citedby": "92"}, {"bib": {"title": "Dystrophin expression and somatic reversion in prednisone\u2010treated and untreated Duchenne dystrophy", "year": "1991"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:HDshCWvjkbEC", "citedby": "90"}, {"bib": {"title": "Association between Ag1-CA alleles and severity of autosomal recessive proximal spinal muscular atrophy", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:dhFuZR0502QC", "citedby": "86"}, {"bib": {"title": "A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:hFOr9nPyWt4C", "citedby": "86"}, {"bib": {"title": "Natural history of infantile\u2010onset spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:F9fV5C73w3QC", "citedby": "79"}, {"bib": {"title": "DAX1 mutations map to putative structural domains in a deduced three-dimensional model", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:IWHjjKOFINEC", "citedby": "79"}, {"bib": {"title": "The land between Mendelian and multifactorial inheritance", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:qUcmZB5y_30C", "citedby": "77"}, {"bib": {"title": "134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy11\u201313 February 2005Naarden, The Netherlands", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:BwyfMAYsbu0C", "citedby": "76"}, {"bib": {"title": "A large animal model of spinal muscular atrophy and correction of phenotype", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:-FonjvnnhkoC", "citedby": "75"}, {"bib": {"title": "Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:CHSYGLWDkRkC", "citedby": "75"}, {"bib": {"title": "Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis.", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:TQgYirikUcIC", "citedby": "71"}, {"bib": {"title": "Antisense oligonucleotides for the treatment of spinal muscular atrophy", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:p2g8aNsByqUC", "citedby": "68"}, {"bib": {"title": "Spinal muscular atrophy: development and implementation of potential treatments", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:l7t_Zn2s7bgC", "citedby": "66"}, {"bib": {"title": "Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:BqipwSGYUEgC", "citedby": "65"}, {"bib": {"title": "Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:k_IJM867U9cC", "citedby": "65"}, {"bib": {"title": "Duchenne muscular dystrophy gene expression in normal and diseased human muscle", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:iH-uZ7U-co4C", "citedby": "61"}, {"bib": {"title": "Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:M3NEmzRMIkIC", "citedby": "59"}, {"bib": {"title": "Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:bEWYMUwI8FkC", "citedby": "58"}, {"bib": {"title": "A multicopy dinucleotide marker that maps close to the spinal muscular atrophy gene", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:j3f4tGmQtD8C", "citedby": "58"}, {"bib": {"title": "The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:2P1L_qKh6hAC", "citedby": "57"}, {"bib": {"title": "Baseline results of the Neuro NEXT spinal muscular atrophy infant biomarker study", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:YohjEiUPhakC", "citedby": "54"}, {"bib": {"title": "Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:O3NaXMp0MMsC", "citedby": "50"}, {"bib": {"title": "Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene.", "year": "1989"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:JV2RwH3_ST0C", "citedby": "48"}, {"bib": {"title": "The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:SP6oXDckpogC", "citedby": "45"}, {"bib": {"title": "Antisense oligonucleotides and spinal muscular atrophy: skipping along", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:u_35RYKgDlwC", "citedby": "45"}, {"bib": {"title": "The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:RYcK_YlVTxYC", "citedby": "45"}, {"bib": {"title": "Absence of gemin5 from SMN complexes in nuclear Cajal bodies", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:HoB7MX3m0LUC", "citedby": "44"}, {"bib": {"title": "A YAC contig of the region containing the spinal muscular atrophy gene (SMA): identification of an unstable region", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NMxIlDl6LWMC", "citedby": "44"}, {"bib": {"title": "Enhancement of resolution in two\u2010dimensional gel electrophoresis and simultaneous resolution of acidic and basic proteins", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:blknAaTinKkC", "citedby": "43"}, {"bib": {"title": "Refined physical map of the spinal muscular atrophy gene (SMA) region at 5q13 based on YAC and cosmid contiguous arrays", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:GnPB-g6toBAC", "citedby": "41"}, {"bib": {"title": "Linkage mapping of the spinal muscular atrophy gene", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:lSLTfruPkqcC", "citedby": "40"}, {"bib": {"title": "Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene", "year": "2011"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:abG-DnoFyZgC", "citedby": "38"}, {"bib": {"title": "Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ldfaerwXgEUC", "citedby": "38"}, {"bib": {"title": "SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMN\u03947 mouse model of SMA", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:FPJr55Dyh1AC", "citedby": "37"}, {"bib": {"title": "A novel method for oral delivery of drug compounds to the neonatal SMN\u03947 mouse model of spinal muscular atrophy", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:bFI3QPDXJZMC", "citedby": "37"}, {"bib": {"title": "Electrophysiological biomarkers in spinal muscular atrophy: proof of concept", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:nRpfm8aw39MC", "citedby": "36"}, {"bib": {"title": "Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NaGl4SEjCO4C", "citedby": "35"}, {"bib": {"title": "Novel receptor protein tyrosine phosphatase (RPTP\u03c1) and acidic fibroblast growth factor (FGF\u20101) transcripts delineate a rostrocaudal boundary in the granule cell layer of the \u2026", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:35N4QoGY0k4C", "citedby": "35"}, {"bib": {"title": "The SMN binding protein Gemin2 is not involved in motor axon outgrowth", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:zA6iFVUQeVQC", "citedby": "33"}, {"bib": {"title": "SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:foquWX3nUaYC", "citedby": "32"}, {"bib": {"title": "Hybrids monosomal for human chromosome\u00e15 reveal the presence of a spinal muscular atrophy (SMA) carrier with two SMN1 copies on one chromosome", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:M05iB0D1s5AC", "citedby": "32"}, {"bib": {"title": "Gene delivery to spinal motor neurons", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:J_g5lzvAfSwC", "citedby": "32"}, {"bib": {"title": "Analysis of mutations in the tudor domain of the survival motor neuron protein SMN", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:70eg2SAEIzsC", "citedby": "31"}, {"bib": {"title": "Two 5q13 simple tandem repeat loci are in linkage disequilibrium with type 1 spinal muscular atrophy", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ML0RJ9NH7IQC", "citedby": "31"}, {"bib": {"title": "Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. Identification of the enzyme variant by radioassay in tissue biopsy specimens", "year": "1983"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:pqnbT2bcN3wC", "citedby": "31"}, {"bib": {"title": "Plastin 3 expression does not modify spinal muscular atrophy severity in the\u2206 7 SMA mouse", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:0N-VGjzr574C", "citedby": "30"}, {"bib": {"title": "Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMN\u03947 mouse model of SMA", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ClCfbGk0d_YC", "citedby": "28"}, {"bib": {"title": "Identification and characterization of RPTP\u03c1, a novel RPTP\u03bc/\u03ba-like receptor protein tyrosine phosphatase whose expression is restricted to the central nervous system", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:3s1wT3WcHBgC", "citedby": "28"}, {"bib": {"title": "Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient", "year": "1992"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:vV6vV6tmYwMC", "citedby": "28"}, {"bib": {"title": "The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:rmuvC79q63oC", "citedby": "26"}, {"bib": {"title": "Perspectives on models of spinal muscular atrophy for drug discovery", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:a0OBvERweLwC", "citedby": "25"}, {"bib": {"title": "Mapping of the spinal muscular atrophy (SMA) gene to a 750-kb interval flanked by two new microsatellites", "year": "1995"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:SeFeTyx0c_EC", "citedby": "25"}, {"bib": {"title": "Electrophysiological motor unit number estimation (MUNE) measuring compound muscle action potential (CMAP) in mouse hindlimb muscles", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_axFR9aDTf0C", "citedby": "24"}, {"bib": {"title": "Exon 44 nonsense mutation in two\u2010duchenne muscular dystrophy brothers detected by heteroduplex analysis", "year": "1993"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:rO6llkc54NcC", "citedby": "24"}, {"bib": {"title": "Expression of the survival of motor neuron (SMN) gene in primary neurons and increase in SMN levels by activation of the N-methyl-D-aspartate glutamate receptor", "year": "2002"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:fPk4N6BV_jEC", "citedby": "22"}, {"bib": {"title": "Analysis of skin fibroblast proteins in Duchenne muscular dystrophy: 2. Isoelectric focusing under dissociating conditions", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:yD5IFk8b50cC", "citedby": "21"}, {"bib": {"title": "Muscle strength and size are associated with motor unit connectivity in aged mice", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:fbc8zXXH2BUC", "citedby": "20"}, {"bib": {"title": "Genomic organization and alternative splicing of the human and mouse RPTP\u03c1 genes", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:D03iK_w7-QYC", "citedby": "20"}, {"bib": {"title": "Molecular genetics of Duchenne and Becker muscular dystrophy", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ZHo1McVdvXMC", "citedby": "20"}, {"bib": {"title": "480. Gene therapy for spinal muscular atrophy type 1 shows potential to improve survival and motor functional outcomes", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4fGpz3EwCPoC", "citedby": "19"}, {"bib": {"title": "Physical mapping at a potential X-linked retinitis pigmentosa locus (RP3) by pulsed-field gel electrophoresis", "year": "1991"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4OULZ7Gr8RgC", "citedby": "19"}, {"bib": {"title": "Does the survival motor neuron protein (SMN) interact with Bcl-2?", "year": "2000"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:dfsIfKJdRG4C", "citedby": "18"}, {"bib": {"title": "Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:bz8QjSJIRt4C", "citedby": "17"}, {"bib": {"title": "SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uLbwQdceFCQC", "citedby": "17"}, {"bib": {"title": "A novel splice site mutation in a Becker muscular dystrophy patient.", "year": "1996"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:nb7KW1ujOQ8C", "citedby": "16"}, {"bib": {"title": "Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene", "year": "1989"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:cFHS6HbyZ2cC", "citedby": "16"}, {"bib": {"title": "Erythrocyte-ghost Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Duchenne muscular dystrophy", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:b0M2c_1WBrUC", "citedby": "15"}, {"bib": {"title": "Analysis of skin fibroblast proteins in Duchenne muscular dystrophy: 1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_xSYboBqXhAC", "citedby": "15"}, {"bib": {"title": "Analysis of cultured skin fibroblasts from patients with Duchenne muscular dystrophy using electrophoretic techniques", "year": "1981"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:f2IySw72cVMC", "citedby": "15"}, {"bib": {"title": "Use of western immunoblot for evaluation of myocardial dystrophin, \u03b1-sarcoglycan, and \u03b2-dystroglycan in dogs with idiopathic dilated cardiomyopathy", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:pyW8ca7W8N0C", "citedby": "14"}, {"bib": {"title": "The application of direct tissue isoelectric focusing to the study of human skeletal muscle", "year": "1981"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:1sJd4Hv_s6UC", "citedby": "14"}, {"bib": {"title": "The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:TIZ-Mc8IlK0C", "citedby": "13"}, {"bib": {"title": "Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:vbGhcppDl1QC", "citedby": "13"}, {"bib": {"title": "DAX1 mutations provide insight into structure-function relationships in steroidogenic tissue development", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ipzZ9siozwsC", "citedby": "13"}, {"bib": {"title": "Gene therapy for muscle diseases.", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:EUQCXRtRnyEC", "citedby": "13"}, {"bib": {"title": "Linkage analysis of a large Latin-American family with X-linked retinitis pigmentosa and metallic sheen in the heterozygote carrier", "year": "1989"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NhqRSupF_l8C", "citedby": "13"}, {"bib": {"title": "Nonsense mutations in a Becker muscular dystrophy and an intermediate patient", "year": "1996"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:xtRiw3GOFMkC", "citedby": "12"}, {"bib": {"title": "Improvements of isoelectric focusing in agarose for direct tissue isoelectric focusing", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:P5F9QuxV20EC", "citedby": "12"}, {"bib": {"title": "Structure of the human alpha 2 subunit gene of the glycine receptor--use of vectorette and Alu-exon PCR.", "year": "1996"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:KxtntwgDAa4C", "citedby": "11"}, {"bib": {"title": "Identification of a missense mutation, single base deletion and a polymorphism in the dystrophin exon 16", "year": "1994"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:dshw04ExmUIC", "citedby": "11"}, {"bib": {"title": "Analysis of genetic muscle disorders by two-dimensional electrophoresis", "year": "1985"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:EkHepimYqZsC", "citedby": "10"}, {"bib": {"title": "Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ALROH1vI_8AC", "citedby": "9"}, {"bib": {"title": "Comparison of focusing in buffers and synthetic carrier ampholytes for use in the first dimension of two dimensional polyacrylamide gel electrophoresis", "year": "1985"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:UxriW0iASnsC", "citedby": "9"}, {"bib": {"title": "Erythrocyte ghost Na+, K+-adenosine triphosphatase in Duchenne muscular dystrophy", "year": "1980"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uWQEDVKXjbEC", "citedby": "9"}, {"bib": {"title": "AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: Event free survival and achievement of developmental milestones", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:cWzG1nlazyYC", "citedby": "8"}, {"bib": {"title": "Other forms of survival motor neuron protein and spinal muscular atrophy: an opinion.", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:URolC5Kub84C", "citedby": "8"}, {"bib": {"title": "Spinal muscular atrophies", "year": "2002"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:OU6Ihb5iCvQC", "citedby": "8"}, {"bib": {"title": "thi Man, N., Burghes, AH, and Morris, GE 2001. Nuclear gems and Cajal (coiled) bodies in fetal tissues: Nucleolar distribution of the spinal muscular atrophy protein, SMN"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:AvfA0Oy_GE0C", "citedby": "8"}, {"bib": {"title": "The problem of Duchenne muscular dystrophy", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:sSrBHYA8nusC", "citedby": "7"}, {"bib": {"title": "Intrathecal delivery of recombinant adeno-associated virus 9", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:86PQX7AUzd4C", "citedby": "5"}, {"bib": {"title": "SMN blood levels in a porcine model of spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:WJVC3Jt7v1AC", "citedby": "5"}, {"bib": {"title": "Mammalian models of spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:6ZxmRoH8BuwC", "citedby": "5"}, {"bib": {"title": "Normalization of patient-identified plasma biomarkers in SMN\u03947 mice following postnatal SMN restoration", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LO7wyVUgiFcC", "citedby": "5"}, {"bib": {"title": "A HindIII/BglII dystrophin gene polymorphism in the African-American population", "year": "1992"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Tiz5es2fbqcC", "citedby": "5"}, {"bib": {"title": "Partial gene duplication in Duchenne and Becker muscular dystrophy", "year": "1988"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Z5m8FVwuT1cC", "citedby": "5"}, {"bib": {"title": "High Resolution Two-dimensional Polyacrylamide-gel Electrophoresis", "year": "1986"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:K3LRdlH-MEoC", "citedby": "5"}, {"bib": {"title": "Two-dimensional electrophoretic analysis of genetic muscle disorders", "year": "1985"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uWiczbcajpAC", "citedby": "5"}, {"bib": {"title": "AVXS-101 phase 1 gene replacement therapy clinical trial in SMA type 1: continued event free survival and achievement of developmental milestones (S29. 001)", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:nVrZBo8bIpAC", "citedby": "4"}, {"bib": {"title": "AVXS-101 phase 1 gene therapy clinical trial in SMA type 1: end-of-study event free survival and achievement of developmental milestones", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:fFSKOagxvKUC", "citedby": "4"}, {"bib": {"title": "Let all DNA vote: who are the amyotrophic lateral sclerosis candidates?", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:WbkHhVStYXYC", "citedby": "4"}, {"bib": {"title": "T. Hao le, TT Le, CA Sewry, C. Ampe, AH Burghes, and GE Morris. 2005. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like \u2026"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:BUYA1_V_uYcC", "citedby": "4"}, {"bib": {"title": "244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10\u201312, 2019, Hoofdorp, The Netherlands", "year": "2020"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:7Hz3ACDFbsoC", "citedby": "3"}, {"bib": {"title": "Frame system formed from single sheet and transparent cover", "year": "2003"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:U4n9YNQMCAIC", "citedby": "3"}, {"bib": {"title": "The spinal muscular atrophy protein, SMN, fails to form nuclear gems in some mammalian cell types which also lack coiled bodies.", "year": "1999"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:08ZZubdj9fEC", "citedby": "3"}, {"bib": {"title": "Sequence differences and promoter analysis of the survival motor neuron (SMNC and SMNT) genes.", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:vRqMK49ujn8C", "citedby": "3"}, {"bib": {"title": "Polyacrylamide-gel-electrophoretic analysis of cultured skin fibroblasts from patients with Duchenne muscular dystrophy", "year": "1981"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:VOx2b1Wkg3QC", "citedby": "3"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Continued Independence from Nutritional and Ventilatory Support in Patients Dosed Early in Disease \u2026", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:lvd772isFD0C", "citedby": "2"}, {"bib": {"title": "Variable phenotypic expression and onset in MYH14 distal hereditary motor neuropathy phenotype in a large, multigenerational North American family", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_FM0Bhl9EiAC", "citedby": "2"}, {"bib": {"title": "Extensive dose ranging study of AVXS-101 in the severe d7 SMA mouse model", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4vMrXwiscB8C", "citedby": "2"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Experience with pre-existing anti-AAV9 antibody in the SMA1 population (S13. 001)", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:QYdC8u9Cj1oC", "citedby": "2"}, {"bib": {"title": "Reply to Ogino and Wilson", "year": "2002"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:sNmaIFBj_lkC", "citedby": "2"}, {"bib": {"title": "AVXS-101 phase 1 gene replacement therapy clinical trial in spinal muscular atrophy type 1 (SMA1): 24-month event-free survival and achievement of developmental milestones", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:4xDN1ZYqzskC", "citedby": "1"}, {"bib": {"title": "IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:PVgj2kMGcgYC", "citedby": "1"}, {"bib": {"title": "SMA THERAPIES I: P. 177AVXS-101 phase 1 gene therapy clinical trial in spinal muscular atrophy type 1: event-free survival and achievement of developmental milestones", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LgRImbQfgY4C", "citedby": "1"}, {"bib": {"title": "Mild SMN missense alleles are only functional in the presence of SMN2 in mammals", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:vDZJ-YLwNdEC", "citedby": "1"}, {"bib": {"title": "AVXS-101 phase 1 gene therapy clinical trial in SMA type 1: event-free survival and achievement of developmental milestones", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:BJbdYPG6LGMC", "citedby": "1"}, {"bib": {"title": "Antisense oligonucleotides for treatment of spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:HtEfBTGE9r8C", "citedby": "1"}, {"bib": {"title": "ESGCT XXV Anniversary Congress in Collaboration with the German Society for Gene Therapy October 17\u201320, 2017 Berlin, Germany", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:yqoGN6RLRZoC", "citedby": "1"}, {"bib": {"title": "AVXS-101 phase 1 gene therapy clinical trial in SMA type 1: patients treated early with the proposed therapeutic dose were able to sit unassisted at a younger age", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:OR75R8vi5nAC", "citedby": "1"}, {"bib": {"title": "Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:SpbeaW3--B0C", "citedby": "1"}, {"bib": {"title": "Variable phenotypic expression and onset in MYH14 distal HMN phenotype in a large, multigenerational North American family", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Bg7qf7VwUHIC", "citedby": "1"}, {"bib": {"title": "Facilitating orphan drug development: proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:GFxP56DSvIMC", "citedby": "1"}, {"bib": {"title": "AVXS-101 phase 1 gene therapy clinical trial in SMA type 1: interim data demonstrates improvements in supportive care use", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:mNrWkgRL2YcC", "citedby": "1"}, {"bib": {"title": "Avxs-101 Phase 1 Gene Therapy Clinical Trial In Sma Type 1: Interim Data Demonstrates Improvements In Survival, Motor Function, And Decreased Dependence On Ventilator Support", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:BzfGm06jWhQC", "citedby": "1"}, {"bib": {"title": "AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: correlation between CHOP-INTEND and motor milestone achievements (S13. 002)", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:9c2xU6iGI7YC", "citedby": "1"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of developmental milestones (CT. 003)", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:IUKN3-7HHlwC", "citedby": "1"}, {"bib": {"title": "Genetics of spinal muscular atrophy", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:DJbcl8HfkQkC", "citedby": "1"}, {"bib": {"title": "Electrical Impedance Myography as a Pharmacodynamic Biomarker in Spinal Muscular Atrophy (P2. 004)", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ruyezt5ZtCIC", "citedby": "1"}, {"bib": {"title": "The motor neuron response to SMN1 deficiency in spinal muscular atrophy.", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:kz9GbA2Ns4gC", "citedby": "1"}, {"bib": {"title": "A tetracycline that corrects SMN2 splicing for potential therapy of spinal muscular atrophy (SMA)", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:eJXPG6dFmWUC", "citedby": "1"}, {"bib": {"title": "Spinal muscular atrophy: Where does survival motor neuron (SMN) protein live these days?", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:geHnlv5EZngC", "citedby": "1"}, {"bib": {"title": "Beneficial effects of valproic acid and hydroxyurea in a mouse model of spinal muscular atrophy (SMA)", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:tOudhMTPpwUC", "citedby": "1"}, {"bib": {"title": "Electrophoretic analysis of proteins in Duchenne muscular dystrophy", "year": "1984"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:cK4Rrx0J3m0C", "citedby": "1"}, {"bib": {"title": "Analysis of Genetic Neuromuscular Diseases by 2D-PAGE: A System for Comparisons", "year": "1984"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LPZeul_q3PIC", "citedby": "1"}, {"bib": {"title": "Erythrocyte membrane (Ca2+ + Mg2+)-activated adenosine triphosphatase in Duchenne muscular dystrophy", "year": "1981"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Ri6SYOTghG4C", "citedby": "1"}, {"bib": {"title": "Improving NMJ Transmission Fidelity: An Additional Target in SMA?(1999)", "year": "2020"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:FiytvqdAVhgC", "citedby": "0"}, {"bib": {"title": "Antisense Oligonucleotides for Treatment of Spinal Muscular Atrophy", "year": "2020"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:7BrZ7Jt4UNcC", "citedby": "0"}, {"bib": {"title": "O. 24Biodistribution of onasemnogene abeparvovec (AVXS-101) DNA, mRNA, and SMN protein in human tissue", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:kVjdVfd2voEC", "citedby": "0"}, {"bib": {"title": "Intrathecal delivery of recombinant adeno-associated virus 9", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:v1_lew4L6wgC", "citedby": "0"}, {"bib": {"title": "Methods and compositions for treating disorders and diseases using Survival Motor Neuron (SMN) protein", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uDGL6kOW6j0C", "citedby": "0"}, {"bib": {"title": "Intrathecal delivery of recombinant adeno-associated virus 9", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:43bX7VzcjpAC", "citedby": "0"}, {"bib": {"title": "INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:zCSUwVk65WsC", "citedby": "0"}, {"bib": {"title": "INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:jgBuDB5drN8C", "citedby": "0"}, {"bib": {"title": "Intrathecal delivery of recombinant adeno-associated virus 9", "year": "2019"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ubry08Y2EpUC", "citedby": "0"}, {"bib": {"title": "Changing the Face of Modern Medicine: Stem Cell and Gene Therapy Organized Jointly by the European Society of Gene & Cell Therapy (ESGCT), International Society for Stem Cell \u2026", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:0CzhzZyukY4C", "citedby": "0"}, {"bib": {"title": "SMA THERAPIES I: P. 180AVXS-101 phase 1 gene replacement therapy clinical trial in spinal muscular atrophy type 1: patients treated early with the proposed therapeutic dose \u2026", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:F1b5ZUV5XREC", "citedby": "0"}, {"bib": {"title": "Spinal muscular atrophy from gene to treatment", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NyGDZy8z5eUC", "citedby": "0"}, {"bib": {"title": "Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene.", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Ak0FvsSvgGUC", "citedby": "0"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Continued Event-Free Survival, Achievement of Developmental Milestones, and Continued Respiratory and Nutritional \u2026", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:gKiMpY-AVTkC", "citedby": "0"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Patients Treated Early with the Proposed Therapeutic Dose Were Able to Sit Unassisted at a Younger Age \u2026", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:gVv57TyPmFsC", "citedby": "0"}, {"bib": {"title": "Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "GENE TRANSFER AND TRANSLATION IN NEUROMUSCULAR DISEASE", "year": "2018"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:u-coK7KVo8oC", "citedby": "0"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Ventilation Support Free Survival and Achievement of Developmental Milestones", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:_OXeSy2IsFwC", "citedby": "0"}, {"bib": {"title": "AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Patients Treated Early with the Proposed Therapeutic Dose were Able to Sit Unassisted at a Younger Age", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:a3BOlSfXSfwC", "citedby": "0"}, {"bib": {"title": "Identification of variants that affect severity of the spinal muscular atrophy phenotype within and outside of the SMN2 gene", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:3htObqc8RwsC", "citedby": "0"}, {"bib": {"title": "AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: decreased need of ventilatory and nutritional support at End-of-Study", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "CSF delivery of AAV9-mediated gene therapy for SMA, a lethal neuromuscular disease in children: a dose-response study in mice and nonhuman primates (P3. 133)", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:HIFyuExEbWQC", "citedby": "0"}, {"bib": {"title": "A96 BEST OF PEDIATRICS: Avxs-101 Phase 1 Gene Therapy Clinical Trial In Sma Type 1: Interim Data Demonstrates Improvements In Survival, Motor Function, And Decreased Dependence \u2026", "year": "2017"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:dBIO0h50nwkC", "citedby": "0"}, {"bib": {"title": "Changing the Face of Modern Medicine: Stem Cells and Gene Therapy Florence, Italy October 18\u201321, 2016 Abstracts", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:r_AWSJRzSzQC", "citedby": "0"}, {"bib": {"title": "From bench to bedside: a novel approach in the treatment of SMA Type 1 with gene therapy", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NXb4pA-qfm4C", "citedby": "0"}, {"bib": {"title": "AVXS-101 phase I gene therapy clinical trial in SMA Type 1", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:0izLItjtcgwC", "citedby": "0"}, {"bib": {"title": "From Mapping Survival Motor Neuron to Treatment of Spinal Muscular Atrophy", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "Interim Safety, Efficacy and Achievement of Developmental Milestones in this Phase 1, First-In-Human Study of the Systemic Delivery of AVXS-101, an AAV9-Mediated Gene Therapy \u2026", "year": "2016"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:XvxMoLDsR5gC", "citedby": "0"}, {"bib": {"title": "ASSOCIATION STUDIES ARTICLES", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "Response of biomarkers to treatment in mouse models of spinal muscular atrophy and response of SMA mice to later treatment", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Variability of expression in MYH14 distal SMA phenotype: A single-family, multi-generational evaluation (P2. 028)", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:q3CdL3IzO_QC", "citedby": "0"}, {"bib": {"title": "Sa1380 A Novel Approach to Identify Genes Related to Functional Gastrointestinal Disorders", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Ug5p-4gJ2f0C", "citedby": "0"}, {"bib": {"title": "A Novel Approach to Identify Genes Related to FGID", "year": "2015"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:xtoqd-5pKcoC", "citedby": "0"}, {"bib": {"title": "GO 16: Reliability and validity of the ACTIVE-mini (Ability Captured Through Interactive Video Evaluation-mini) to quantify infant movement", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:9pM33mqn1YgC", "citedby": "0"}, {"bib": {"title": "GO 15: Effect of early and late restoration of SMN in SMA animal models and identification of genes downstream of SMN", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:M7yex6snE4oC", "citedby": "0"}, {"bib": {"title": "High Resolution", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "AAVHSC15 and AAVHSC17 Cross the Blood Brain Barrier and Transduce Neurons and Astrocytes Like AAV9", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:k8Z6L05lTy4C", "citedby": "0"}, {"bib": {"title": "Differences in CNS Transduction Following Systemic Injection of AAV9 in Aged and Young Adult Mice", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:VaXvl8Fpj5cC", "citedby": "0"}, {"bib": {"title": "Electrophysiological Motor Unit Function in SMN\u03947 Mice Following SMN Restoration (P7. 114)", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:kuK5TVdYjLIC", "citedby": "0"}, {"bib": {"title": "O12 Antisense approaches to counter skeletal muscle atrophy and fibrosis: targeting myostatin and other strategies", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "O10 Development of PMO antisense oligonucleotides for treatment of Spinal muscular atrophy", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ILKRHgRFtOwC", "citedby": "0"}, {"bib": {"title": "Electrophysiological biomarkers in spinal muscular atrophy: proof of concept", "year": "2014"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "O. 7 Spinal muscular atrophy: How it works and therapeutic targets", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:S16KYo8Pm5AC", "citedby": "0"}, {"bib": {"title": "ASSOCIATION STUDIES ARTICLES", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:OTTXONDVkokC", "citedby": "0"}, {"bib": {"title": "Applicability and Utility of Nerve Conduction Studies in Early Postnatal SMN\u03947 Mice (P03. 046)", "year": "2013"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:KUbvn5osdkgC", "citedby": "0"}, {"bib": {"title": "Harnessing a Physiologic Mechanism for siRNA Delivery with Mimetic Lipoprotein Particles.", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:tH6gc1N1XXoC", "citedby": "0"}, {"bib": {"title": "This chapter has been published in the peer-reviewed journal Molecular Therapy. This work is the result of collaboration with the authors listed below. I helped design and \u2026", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LI9QrySNdTsC", "citedby": "0"}, {"bib": {"title": "This work is the result of collaboration with the authors listed below. I designed and performed experiments and wrote the manuscript.", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:lmc2jWPfTJgC", "citedby": "0"}, {"bib": {"title": "This work was published in the peer-reviewed journal Human Molecular Genetics, and it is the result of collaboration with the authors listed below. I designed and performed \u2026", "year": "2012"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:MLfJN-KU85MC", "citedby": "0"}, {"bib": {"title": "Motoneuron transplantation rescues the phenotype of SMARD1 (spinal muscular atrophy with respiratory distress type 1). J Neuroscience 2009; 29: 11761-11771", "year": "2010"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:otzGkya1bYkC", "citedby": "0"}, {"bib": {"title": "PMCID: PMC26877.", "year": "2008"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:MpfHP-DdYjUC", "citedby": "0"}, {"bib": {"title": "Erratum: The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/-mice and results in a mouse with spinal muscular atrophy (Human Molecular \u2026", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:buQ7SEKw-1sC", "citedby": "0"}, {"bib": {"title": "PMC2064134.", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ZzlSgRqYykMC", "citedby": "0"}, {"bib": {"title": "SMN and SMA how does it all fit together", "year": "2007"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:i2xiXl-TujoC", "citedby": "0"}, {"bib": {"title": "The US riluzole placebo controlled, randomized trial in SMA type 1 [38]", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "Substantial immune suppression required in gene therapy for muscular dystrophy?", "year": "2005"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:p__nRnzSRKYC", "citedby": "0"}, {"bib": {"title": "VEGF gene therapy with retrogradely transported lentivirus prolongs survival in mouse ALS model", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:8xutWZnSdmoC", "citedby": "0"}, {"bib": {"title": "GENES: STRUCTURE AND REGULATION-Identification of a Novel Cyclic AMP-response Element (CRE-II) and the Role of CREB-1 in the cAMP-induced Expression of the Survival Motor \u2026", "year": "2004"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uJ-U7cs_P_0C", "citedby": "0"}, {"bib": {"title": "Erratum: The exon 2b region of the spinal muscular atophy protein, SMN, is involved in self-association and SIP1 binding (Human Molecular Genetics (2000) vol. 9 (2869-2877))", "year": "2001"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:CaZNVDsoPx4C", "citedby": "0"}, {"bib": {"title": "Reply to Mackenzie", "year": "1998"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:NJ774b8OgUMC", "citedby": "0"}, {"bib": {"title": "MOLECULAR MARKERS WHICH DELINEATE ANTERIOR-POSTERIOR COMPARTMENTS IN THE DEVELOPING MOUSE CEREBELLUM.", "year": "1997"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:DUooU5lO8OsC", "citedby": "0"}, {"bib": {"title": "XLRP (RP3): FURTHER LINKAGE DATA, PHYSICALMAPPING OF", "year": "1991"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:uc_IGeMz5qoC", "citedby": "0"}, {"bib": {"title": "THE DXS206 LOCUS IS PART OF THE DUCHENNE MUSCULAR-DYSTROPHY GENE", "year": "1987"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "INVESTIGATION OF ALTERNATIVE GEL MEDIA AND DENATURANTS AND A COMPARISON OF BUFFER FOCUSING WITH CARRIER AMPHOLYTES FOR USE IN THE FIRST DIMENSION OF 2D-PAGE", "year": "1984"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:ZfRJV9d4-WMC", "citedby": "0"}, {"bib": {"title": "Enzymes and Enzyme Kinetics", "year": "1982"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:j7_hQOaDUrUC", "citedby": "0"}, {"bib": {"title": "Immunohistochemical Analysis of Dystrophin-associated Proteins in Becker/Duchenne Muscular Dystrophy with Huge ln-frame Deletions in the NH,-Terminal and Rod Domains of Dystrophin"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:IaI1MmNe2tcC", "citedby": "0"}, {"bib": {"title": "Temporal requirement for high SMN expression in SMA mice."}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:PaBasH6fAo0C", "citedby": "0"}, {"bib": {"title": "Poster number 51 submitted by Corey Ruhno"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:LdasjJ6CEcoC", "citedby": "0"}, {"bib": {"title": "The 20 th Anniversary of the DMD gene discovery: Impact on muscle biology, disease, and therapy May 3\u20135, 2007--The Westin Hotel, Ottawa, Canada"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:Ehil0879vHcC", "citedby": "0"}, {"bib": {"title": "Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using screen and mutation analysis"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:nZcligLrVowC", "citedby": "0"}, {"bib": {"title": "The Duchenne muscular dystrophy gene product is localized in sarcolemma"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "Polymeropoulos, MH 652,658 Price. DA 579 Price. RA 655"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:bKqednn6t2AC", "citedby": "0"}, {"bib": {"title": "Early heart failure in the \u03947SMN model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:HtS1dXgVpQUC", "citedby": "0"}, {"bib": {"title": "Influence of housing, feeding, and handling conditions on SMA mouse performance"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:kh2fBNsKQNwC", "citedby": "0"}, {"bib": {"title": "Grip strength"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "Commentary 2 on \u201cMotoneuron transplantation rescues the phenotype of SMARD1\u2026\u201d"}, "source": "citations", "id_citations": "NqDgVtcAAAAJ:eq2jaN3J8jMC", "citedby": "0"}]}